Treatment for newly-diagnosed Type 2 diabetes –Shared Decision Making 新診斷第2型糖尿病治療的選擇-醫病共享決策 | 衛教單張 - 中國醫藥大學附設醫院

Health Information

Health Education

:::

Treatment for newly-diagnosed Type 2 diabetes –Shared Decision Making 新診斷第2型糖尿病治療的選擇-醫病共享決策

Treatment for newly-diagnosed Type 2 diabetes –Shared Decision Making 新診斷第2型糖尿病治療的選擇-醫病共享決策

Treatment for newly-diagnosed Type 2 diabetes –Shared Decision Making 新診斷第2型糖尿病治療的選擇-醫病共享決策

2025/4/14

	Oral antidiabetic agent	GLP-1 receptor agonist	Insulin	Lifestyle modification and diet control

Application	Several pills a day	Once a week	Once daily, or multiple times a day	1. Balanced diet: Avoid eating too much food that will raise blood glucose (1) Whole grains (2) Fruits (3) Dairies 2.Exercise: (1) Aerobics (2) Resistance (3) Stretching 3. Weight reduction
Advantage	Convenience	1. Stable blood glucose level 2. Less hypoglycemia 3. Reducing the appetite and body weight 4. Heart and renal protection	1. Excellent effect in control blood glucose 2. Dosage can be adjusted according to the blood glucose level 3. May be used with renal/live function insufficiency or during pregnancy
Disadvantage	Limited option in case of liver function/renal function impairment	1. Need to learn the injection skill 2. Possible local reaction of injection site 3. Potential side effects of nausea and vomiting	1. Need to learn the injection skills 2. Possible local reaction of injection site 3. Potential hypoglycemic event 4. Weight gain
Covered by National Health Insurance	Yes	Payment under certain condition	Yes

Reference

社團法人中華民國糖尿病學會（2022）．2022第2型糖尿病臨床照護指引．社團法人中華民國糖尿病學會。
American Diabetes Association.

製作單位：內科部內分泌暨新陳代謝系　編碼：HE-10310-E
若有任何疑問，請不吝與我們聯絡
電話：(04) 22052121 分機 13229、13246

中國醫藥大學附設醫院暨體系院所

回上頁

}

側邊開關圖示

中國醫點通